Search Results - "Aokage, Keiju"

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial by Suzuki, Kenji, Saji, Hisashi, Aokage, Keiju, Watanabe, Shun-ichi, Okada, Morihito, Mizusawa, Junki, Nakajima, Ryu, Tsuboi, Masahiro, Nakamura, Shinichiro, Nakamura, Kenichi, Mitsudomi, Tetsuya, Asamura, Hisao

“…No definitive comparisons of surgical morbidity between segmentectomy and lobectomy for non–small cell lung cancer have been reported. We conducted a…”
Get full text

A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer by Suzuki, Kenji, Watanabe, Shun-ichi, Wakabayashi, Masashi, Saji, Hisashi, Aokage, Keiju, Moriya, Yasumitsu, Yoshino, Ichiro, Tsuboi, Masahiro, Nakamura, Shinichiro, Nakamura, Kenichi, Mitsudomi, Tetsuya, Asamura, Hisao

“…The optimal mode of surgery for ground-glass opacity dominant peripheral lung cancer defined with thoracic thin-section computed tomography remains unknown. We…”
Get full text

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies by Kumagai, Shogo, Togashi, Yosuke, Kamada, Takahiro, Sugiyama, Eri, Nishinakamura, Hitomi, Takeuchi, Yoshiko, Vitaly, Kochin, Itahashi, Kota, Maeda, Yuka, Matsui, Shigeyuki, Shibahara, Takuma, Yamashita, Yasuho, Irie, Takuma, Tsuge, Ayaka, Fukuoka, Shota, Kawazoe, Akihito, Udagawa, Hibiki, Kirita, Keisuke, Aokage, Keiju, Ishii, Genichiro, Kuwata, Takeshi, Nakama, Kenta, Kawazu, Masahito, Ueno, Toshihide, Yamazaki, Naoya, Goto, Koichi, Tsuboi, Masahiro, Mano, Hiroyuki, Doi, Toshihiko, Shitara, Kohei, Nishikawa, Hiroyoshi

“…Immune checkpoint blockade has provided a paradigm shift in cancer therapy, but the success of this approach is very variable; therefore, biomarkers predictive…”
Get full text

Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung by Miyoshi, Tomohiro, Umemura, Shigeki, Matsumura, Yuki, Mimaki, Sachiyo, Tada, Satoshi, Makinoshima, Hideki, Ishii, Genichiro, Udagawa, Hibiki, Matsumoto, Shingo, Yoh, Kiyotaka, Niho, Seiji, Ohmatsu, Hironobu, Aokage, Keiju, Hishida, Tomoyuki, Yoshida, Junji, Nagai, Kanji, Goto, Koichi, Tsuboi, Masahiro, Tsuchihara, Katsuya

“…Although large-cell neuroendocrine carcinoma (LCNEC) of the lung shares many clinical characteristics with small-cell lung cancer (SCLC), little is known about…”
Get full text

Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma by Miyoshi, Tomohiro, Aokage, Keiju, Katsumata, Shinya, Tane, Kenta, Ishii, Genichiro, Tsuboi, Masahiro

“…A ground-glass opacity (GGO) component on chest computed tomography (CT) pathologically corresponds to lepidic adenocarcinoma. However, the precise…”
Get full text

Prognostic impact of a ground-glass opacity component in clinical stage IA non–small cell lung cancer by Hattori, Aritoshi, Suzuki, Kenji, Takamochi, Kazuya, Wakabayashi, Masashi, Aokage, Keiju, Saji, Hisashi, Watanabe, Shun-ichi, Tsutani, Yasuhiro, Yoshioka, Hiroshige, Satoshi, Shiono, Ito, Hiroyuki, Aoki, Tadashi, Nakagawa, Kazuo, Okami, Jiro, Okada, Morihito, Mizutani, Tomonori, Shimoyama, Ryo, Fukuda, Haruhiko

“…We performed a validation study to confirm the prognostic importance of the presence of a ground-glass opacity component based on data of the Japan Clinical…”
Get full text

Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review by Aokage, Keiju, Yoshida, Junji, Hishida, Tomoyuki, Tsuboi, Masahiro, Saji, Hisashi, Okada, Morihito, Suzuki, Kenji, Watanabe, Syunichi, Asamura, Hisao

“…Since 'radical lobectomy' was reported by Cahan in 1960, the standard surgical care for lung cancer has been lobectomy, in which units of the lobe are excised…”
Get full text

A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I–II non-small cell lung cancer (JCOG1413) by Hishida, Tomoyuki, Saji, Hisashi, Watanabe, Shun-ichi, Asamura, Hisao, Aokage, Keiju, Mizutani, Tomonori, Wakabayashi, Masashi, Shibata, Taro, Okada, Morihito

“…A randomized Phase III trial was commenced to confirm the clinical benefit of lobe-specific nodal dissection in comparison to systematic nodal dissection for…”
Get full text

Real-world perioperative outcomes of segmentectomy versus lobectomy for early-stage lung cancer: a propensity score-matched analysis by Ichinose, Junji, Yamamoto, Hiroyuki, Aokage, Keiju, Kondo, Haruhiko, Sato, Yukio, Suzuki, Kenji, Chida, Masayuki

“…This study aimed to compare the real-world outcomes of segmentectomy and lobectomy for lung cancer after adjusting for background factors and the extent of…”
Get full text

Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma by Suzuki, Jun, Aokage, Keiju, Neri, Shinya, Sakai, Takashi, Hashimoto, Hiroko, Su, Yinghan, Yamazaki, Shota, Nakamura, Hiroshi, Tane, Kenta, Miyoshi, Tomohiro, Sugano, Masato, Kojima, Motohiro, Fujii, Satoshi, Kuwata, Takeshi, Ochiai, Atsushi, Tsuboi, Masahiro, Ishii, Genichiro

“…•Podoplanin (PDPN)+ cancer associated fibroblasts (CAFs) promotes cancer progression in non-small cell lung cancer.•PDPN+ CAFs showed higher expression of…”
Get full text

Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303 by Mimae, Takahiro, Saji, Hisashi, Nakamura, Hiroshige, Okumura, Norihito, Tsuchida, Masanori, Sonobe, Makoto, Miyazaki, Takuro, Aokage, Keiju, Nakao, Masayuki, Haruki, Tomohiro, Okada, Morihito, Suzuki, Kenji, Chida, Masayuki

“…Background Anatomic resection with lymph node dissection or sampling is the standard treatment for early non-small cell lung cancer (NSCLC), and wedge…”
Get full text

Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival by Hishida, Tomoyuki, Yoshida, Junji, Aokage, Keiju, Nagai, Kanji, Tsuboi, Masahiro

“…OBJECTIVES Postoperative recurrences of non-small-cell lung cancer (NSCLC) are usually disseminated and systemic. Recently, the concept of oligo-recurrence,…”
Get full text

Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectum by Konishi, Yasuhito, Taki, Tetsuro, Nakai, Tokiko, Kuroe, Takashi, Morisue, Ryo, Miyoshi, Tomohiro, Tane, Kenta, Samejima, Joji, Aokage, Keiju, Miyazaki, Saori, Sakamoto, Naoya, Sakashita, Shingo, Watanabe, Reiko, Kojima, Motohiro, Suzuki, Kenji, Tsuboi, Masahiro, Ishii, Genichiro

“…Dirty necrosis (DN) is a form of tumor necrosis (TN) with prominent neutrophil infiltration and cell detritus in the necrotic foci. This study aimed to…”
Get full text

Sublobar Resection for Non–Small Cell Lung Cancer in Octogenarians: A Prospective, Multicenter Study by Mimae, Takahiro, Saji, Hisashi, Nakamura, Hiroshige, Okumura, Norihito, Tsuchida, Masanori, Sonobe, Makoto, Miyazaki, Takuro, Aokage, Keiju, Nakao, Masayuki, Haruki, Tomohiro, Okada, Morihito, Suzuki, Kenji, Yoshino, Ichiro

“…Segmentectomy is a good surgical option for peripheral, early, non–small cell lung cancer (NSCLC) ≤2 cm. However, the role of sublobar resection including…”
Get full text

A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211) by Aokage, Keiju, Saji, Hisashi, Suzuki, Kenji, Mizutani, Tomonori, Katayama, Hiroshi, Shibata, Taro, Watanabe, Syunichi, Asamura, Hisao

“…Introduction Lobectomy has been the standard surgery for even stage I lung cancer since the validity of limited resection for stage I lung cancer was denied by…”
Get full text

Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206 by Kenmotsu, Hirotsugu, Niho, Seiji, Tsuboi, Masahiro, Wakabayashi, Masashi, Ishii, Genichiro, Nakagawa, Kazuo, Daga, Haruko, Tanaka, Hiroshi, Saito, Haruhiro, Aokage, Keiju, Takahashi, Toshiaki, Menju, Toshi, Kasai, Takashi, Yoshino, Ichiro, Minato, Koichi, Okada, Morihito, Eba, Junko, Asamura, Hisao, Ohe, Yuichiro, Watanabe, Shun-Ichi

“…To verify the superiority of irinotecan plus cisplatin over etoposide plus cisplatin as postoperative adjuvant chemotherapy for patients with pathologic stage…”
Get full text

Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment by Niimi, Takahiro, Nakai, Tokiko, Aokage, Keiju, Tane, Kenta, Miyoshi, Tomohiro, Samejima, Joji, Miyazaki, Saori, Taki, Tetsuro, Sakamoto, Naoya, Sakashita, Shingo, Watanabe, Reiko, Kojima, Motohiro, Suzuki, Kenji, Tsuboi, Masahiro, Ishii, Genichiro

“…Extratumoral lymphatic permeation (ly‐ext) has been reported as an independent poor prognostic factor for lung adenocarcinoma, but whether or not the number of…”
Get full text

Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma by Katsumata, Shinya, Aokage, Keiju, Ishii, Genichiro, Hoshino, Hironobu, Suzuki, Jun, Miyoshi, Tomohiro, Tane, Kenta, Samejima, Joji, Tsuboi, Masahiro

“…Purpose To investigate the prognostic implications and pathological features of clinical stage I lung adenocarcinoma with ground-glass opacity (GGO) on…”
Get full text

Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer by Takuwa, Teruhisa, MD, Yoshida, Junji, MD, PhD, Ono, Shotaro, MD, Hishida, Tomoyuki, MD, PhD, Nishimura, Mitsuyo, MD, PhD, Aokage, Keiju, MD, PhD, Nagai, Kanji, MD, PhD

“…Objective We reviewed our experience of iatrogenic chylothorax after pulmonary resection for primary lung cancer to evaluate a low-fat diet management…”
Get full text

Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer by Watanabe, Shun-Ichi, Nakagawa, Kazuo, Suzuki, Kenji, Takamochi, Kazuya, Ito, Hiroyuki, Okami, Jiro, Aokage, Keiju, Saji, Hisashi, Yoshioka, Hiroshige, Zenke, Yoshitaka, Aoki, Tadashi, Tsutani, Yasuhiro, Okada, Morihito

“…The treatments for advanced non-small cell lung cancer (NSCLC) should control both local and microscopic systemic disease, because the 5-year survival of…”
Get full text